Evaluating the utility of procalcitonin and a clinical decision support tool to determine duration of antimicrobial therapy for respiratory tract infections
American Journal of Health-System Pharmacy · 2024
DOI: 10.1093/ajhp/zxae072 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, 2024. Verfasst von Rustin Pevehouse und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Houston Methodist Sugar Land Hospital, Sugar Land, TX, USA. Hauptthemen laut MEDLINE: Decision Support Systems, Clinical, Procalcitonin, Antimicrobial Stewardship, Respiratory Tract Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Purpose
Procalcitonin (PCT) levels may play a role in decreasing the duration of antimicrobial therapy in institutions that have long durations of therapy for management of community-acquired pneumonia. We assessed the impact of the combination of pharmacist stewardship interventions assisted by a clinical decision support (CDS) tool and PCT assessment on the antimicrobial days of therapy (DOT) prescribed for respiratory tract infections (RTIs).
Methods
We conducted a quasi-experimental study in which patients in the preintervention group were admitted between April and June 2021 and patients in the intervention group were admitted between April and June 2022. In the intervention phase, a CDS tool was utilized to alert clinical pharmacists when patients met specific criteria. This alert was programmed to activate for individual patients when a reported PCT level was less than 0.25 ng/mL and the patient was on antimicrobials prescribed for an RTI as indicated by providers in the electronic health record. Stewardship interventions were made by pharmacists via prospective audit and feedback. The primary endpoint was inpatient antimicrobial DOT for RTIs.
Results
There were 90 patients in the preintervention group and 104 patients in the intervention group. Although baseline characteristics were not well matched between the groups, favoring the preintervention group, the median DOT was lower in the intervention group, at 3 days (interquartile range [IQR], 2-4 days), compared to 4 days (IQR, 2.8-5 days) in the preintervention group (P = 0.001).
Conclusion
The results of our study demonstrate the utility of pharmacist interventions coupled with CDS and PCT in reducing antimicrobial DOT prescribed for RTIs. Antimicrobial stewardship programs may benefit from implementing a PCT bundle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Houston Methodist Sugar Land Hospital, Sugar Land, TX, USA.
- Houston Methodist Sugar Land Hospital, Sugar Land, TX, USA.
Zitieren
APA
Pevehouse, R., Shah, P. J., Chou, N., Oolut, P., Nair, S., & Ahmed, R. (2024). Evaluating the utility of procalcitonin and a clinical decision support tool to determine duration of antimicrobial therapy for respiratory tract infections. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxae072
Vancouver
Pevehouse R, Shah PJ, Chou N, Oolut P, Nair S, Ahmed R. Evaluating the utility of procalcitonin and a clinical decision support tool to determine duration of antimicrobial therapy for respiratory tract infections. American Journal of Health-System Pharmacy. 2024. doi:10.1093/ajhp/zxae072
BibTeX
@article{Pevehouse2024,
author = {Pevehouse, Rustin and Shah, Punit J and Chou, Nitha and Oolut, Priya and Nair, Suneesh and Ahmed, Raziuddin},
title = {Evaluating the utility of procalcitonin and a clinical decision support tool to determine duration of antimicrobial therapy for respiratory tract infections},
journal = {American Journal of Health-System Pharmacy},
year = {2024},
doi = {10.1093/ajhp/zxae072}
}
EUVIMED